{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:05:51Z","timestamp":1787796351683,"version":"build-2784847793"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["OPP1032325"],"award-info":[{"award-number":["OPP1032325"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["OPP1032325"],"award-info":[{"award-number":["OPP1032325"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["AI067854"],"award-info":[{"award-number":["AI067854"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["AI100645"],"award-info":[{"award-number":["AI100645"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["AI144371"],"award-info":[{"award-number":["AI144371"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["AI060354"],"award-info":[{"award-number":["AI060354"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1038\/s41590-021-01026-9","type":"journal-article","created":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T16:43:47Z","timestamp":1632415427000},"page":"1294-1305","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccination"],"prefix":"10.1038","volume":"22","author":[{"given":"Jeffrey Alan","family":"Tomalka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam Nicolas","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6609-7587","authenticated-orcid":false,"given":"Slim","family":"Fourati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Bilal","family":"Latif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Furr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0279-2198","authenticated-orcid":false,"given":"Michelle","family":"Lifton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2851-6589","authenticated-orcid":false,"given":"Genoveffa","family":"Franchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Parks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman","family":"Letvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2009-3270","authenticated-orcid":false,"given":"Kelly","family":"Seaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Tomaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3949-9649","authenticated-orcid":false,"given":"Merlin L.","family":"Robb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson L.","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Koup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barton","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8796-1714","authenticated-orcid":false,"given":"Sampa","family":"Santra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafick Pierre","family":"Sekaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,23]]},"reference":[{"key":"1026_CR1","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","volume":"361","author":"S Rerks-Ngarm","year":"2009","unstructured":"Rerks-Ngarm, S. et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 361, 2209\u20132220 (2009).","journal-title":"N. Engl. J. Med."},{"key":"1026_CR2","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1086\/508748","volume":"194","author":"P Pitisuttithum","year":"2006","unstructured":"Pitisuttithum, P. et al. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J. Infect. Dis. 194, 1661\u20131671 (2006).","journal-title":"J. Infect. Dis."},{"key":"1026_CR3","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1086\/428404","volume":"191","author":"NM Flynn","year":"2005","unstructured":"Flynn, N. M. et al. Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. J. Infect. Dis. 191, 654\u2013665 (2005).","journal-title":"J. Infect. Dis."},{"key":"1026_CR4","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","volume":"366","author":"BF Haynes","year":"2012","unstructured":"Haynes, B. F. et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N. Engl. J. Med. 366, 1275\u20131286 (2012).","journal-title":"N. Engl. J. Med."},{"key":"1026_CR5","doi-asserted-by":"publisher","first-page":"e75665","DOI":"10.1371\/journal.pone.0075665","volume":"8","author":"R Gottardo","year":"2013","unstructured":"Gottardo, R. et al. Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial. PLoS ONE 8, e75665 (2013).","journal-title":"PLoS ONE"},{"key":"1026_CR6","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/infdis\/jis367","volume":"206","author":"DC Montefiori","year":"2012","unstructured":"Montefiori, D. C. et al. Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials. J. Infect. Dis. 206, 431\u2013441 (2012).","journal-title":"J. Infect. Dis."},{"key":"1026_CR7","doi-asserted-by":"publisher","first-page":"9019","DOI":"10.1073\/pnas.1301456110","volume":"110","author":"GD Tomaras","year":"2013","unstructured":"Tomaras, G. D. et al. Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG. Proc. Natl Acad. Sci. USA 110, 9019\u20139024 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1026_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nature11519","volume":"490","author":"M Rolland","year":"2012","unstructured":"Rolland, M. et al. Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2. Nature 490, 417\u2013420 (2012).","journal-title":"Nature"},{"key":"1026_CR9","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1128\/JVI.02544-12","volume":"87","author":"P Pegu","year":"2013","unstructured":"Pegu, P. et al. Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIVmac251 acquisition in an immunization regimen that mimics the RV-144 Thai trial. J. Virol. 87, 1708\u20131719 (2013).","journal-title":"J. Virol."},{"key":"1026_CR10","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nm.4105","volume":"22","author":"M Vaccari","year":"2016","unstructured":"Vaccari, M. et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat. Med. 22, 762\u2013770 (2016).","journal-title":"Nat. Med."},{"key":"1026_CR11","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/s41591-018-0025-7","volume":"24","author":"M Vaccari","year":"2018","unstructured":"Vaccari, M. et al. HIV vaccine candidate activation of hypoxia and the inflammasome in CD14+ monocytes is associated with a decreased risk of SIVmac251 acquisition. Nat. Med. 24, 847\u2013856 (2018).","journal-title":"Nat. Med."},{"key":"1026_CR12","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1056\/NEJMoa2031499","volume":"384","author":"GE Gray","year":"2021","unstructured":"Gray, G. E. et al. Vaccine efficacy of ALVAC-HIV and bivalent subtype C gp120-MF59 in adults. N. Engl. J. Med. 384, 1089\u20131100 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1026_CR13","doi-asserted-by":"publisher","first-page":"6376","DOI":"10.1016\/j.vaccine.2006.06.011","volume":"24","author":"Q Yu","year":"2006","unstructured":"Yu, Q. et al. Comparative analysis of tropism between canarypox (ALVAC) and vaccinia viruses reveals a more restricted and preferential tropism of ALVAC for human cells of the monocytic lineage. Vaccine 24, 6376\u20136391 (2006).","journal-title":"Vaccine"},{"key":"1026_CR14","doi-asserted-by":"publisher","first-page":"5004","DOI":"10.1016\/j.vaccine.2008.07.050","volume":"26","author":"A Harenberg","year":"2008","unstructured":"Harenberg, A., Guillaume, F., Ryan, E. J., Burdin, N. & Spada, F. Gene profiling analysis of ALVAC infected human monocyte derived dendritic cells. Vaccine 26, 5004\u20135013 (2008).","journal-title":"Vaccine"},{"key":"1026_CR15","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.imbio.2017.12.001","volume":"223","author":"T Mohan","year":"2018","unstructured":"Mohan, T., Zhu, W., Wang, Y. & Wang, B. Z. Applications of chemokines as adjuvants for vaccine immunotherapy. Immunobiology 223, 477\u2013485 (2018).","journal-title":"Immunobiology"},{"key":"1026_CR16","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1026_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1586\/14760584.7.3.373","volume":"7","author":"L Bracci","year":"2008","unstructured":"Bracci, L., La Sorsa, V., Belardelli, F. & Proietti, E. Type I interferons as vaccine adjuvants against infectious diseases and cancer. Expert Rev. Vaccines 7, 373\u2013381 (2008).","journal-title":"Expert Rev. Vaccines"},{"key":"1026_CR18","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1084\/jem.20082292","volume":"205","author":"D Gaucher","year":"2008","unstructured":"Gaucher, D. et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 205, 3119\u20133131 (2008).","journal-title":"J. Exp. Med."},{"key":"1026_CR19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/ni.1688","volume":"10","author":"TD Querec","year":"2009","unstructured":"Querec, T. D. et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 10, 116\u2013125 (2009).","journal-title":"Nat. Immunol."},{"key":"1026_CR20","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1093\/bioinformatics\/btq466","volume":"26","author":"A Lachmann","year":"2010","unstructured":"Lachmann, A. et al. ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics 26, 2438\u20132444 (2010).","journal-title":"Bioinformatics"},{"key":"1026_CR21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/cdd.2008.160","volume":"16","author":"CY Zhu","year":"2009","unstructured":"Zhu, C. Y. et al. Cell growth suppression by thanatos-associated protein 11(THAP11) is mediated by transcriptional downregulation of c-Myc. Cell Death Differ. 16, 395\u2013405 (2009).","journal-title":"Cell Death Differ."},{"key":"1026_CR22","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1242\/dev.126.8.1739","volume":"126","author":"ME Horb","year":"1999","unstructured":"Horb, M. E. & Thomsen, G. H. Tbx5 is essential for heart development. Development 126, 1739\u20131751 (1999).","journal-title":"Development"},{"key":"1026_CR23","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1242\/dev.122.3.983","volume":"122","author":"MF Offield","year":"1996","unstructured":"Offield, M. F. et al. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 122, 983\u2013995 (1996).","journal-title":"Development"},{"key":"1026_CR24","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1101\/gad.7.5.812","volume":"7","author":"V Baldin","year":"1993","unstructured":"Baldin, V., Lukas, J., Marcote, M. J., Pagano, M. & Draetta, G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7, 812\u2013821 (1993).","journal-title":"Genes Dev."},{"key":"1026_CR25","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1128\/JVI.03061-14","volume":"89","author":"J Delaloye","year":"2015","unstructured":"Delaloye, J. et al. Interleukin-1- and type I interferon-dependent enhanced immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletions of type I and type II interferon-binding proteins. J. Virol. 89, 3819\u20133832 (2015).","journal-title":"J. Virol."},{"key":"1026_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1109\/TNN.2003.809398","volume":"15","author":"V Roth","year":"2004","unstructured":"Roth, V. The generalized LASSO. IEEE Trans. Neural Netw. 15, 16\u201328 (2004).","journal-title":"IEEE Trans. Neural Netw."},{"key":"1026_CR27","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1084\/jem.20022156","volume":"197","author":"P Ancuta","year":"2003","unstructured":"Ancuta, P. et al. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J. Exp. Med. 197, 1701\u20131707 (2003).","journal-title":"J. Exp. Med."},{"key":"1026_CR28","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1182\/blood-2002-09-2773","volume":"102","author":"P Ogilvie","year":"2003","unstructured":"Ogilvie, P., Paoletti, S., Clark-Lewis, I. & Uguccioni, M. Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytes. Blood 102, 789\u2013794 (2003).","journal-title":"Blood"},{"key":"1026_CR29","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ni.1615","volume":"9","author":"C Waskow","year":"2008","unstructured":"Waskow, C. et al. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat. Immunol. 9, 676\u2013683 (2008).","journal-title":"Nat. Immunol."},{"key":"1026_CR30","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1002\/1521-4141(200011)30:11<3147::AID-IMMU3147>3.0.CO;2-J","volume":"30","author":"D Xu","year":"2000","unstructured":"Xu, D. et al. IL-18 induces the differentiation of Th1 or Th2 cells depending upon cytokine milieu and genetic background. Eur. J. Immunol. 30, 3147\u20133156 (2000).","journal-title":"Eur. J. Immunol."},{"key":"1026_CR31","doi-asserted-by":"publisher","first-page":"4303","DOI":"10.4049\/jimmunol.1401505","volume":"193","author":"I Tassi","year":"2014","unstructured":"Tassi, I. et al. The NF-\u03baB regulator Bcl-3 governs dendritic cell antigen presentation functions in adaptive immunity. J. Immunol. 193, 4303\u20134311 (2014).","journal-title":"J. Immunol."},{"key":"1026_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4898","volume":"5","author":"SI Gringhuis","year":"2014","unstructured":"Gringhuis, S. I., Kaptein, T. M., Wevers, B. A., Mesman, A. W. & Geijtenbeek, T. B. Fucose-specific DC-SIGN signalling directs T helper cell type-2 responses via IKK\u03b5- and CYLD-dependent Bcl3 activation. Nat. Commun. 5, 3898 (2014).","journal-title":"Nat. Commun."},{"key":"1026_CR33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1615\/CritRevImmunol.v29.i3.10","volume":"29","author":"WL Redmond","year":"2009","unstructured":"Redmond, W. L., Ruby, C. E. & Weinberg, A. D. The role of OX40-mediated co-stimulation in T-cell activation and survival. Crit. Rev. Immunol. 29, 187\u2013201 (2009).","journal-title":"Crit. Rev. Immunol."},{"key":"1026_CR34","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature07317","volume":"455","author":"H Ishikawa","year":"2008","unstructured":"Ishikawa, H. & Barber, G. N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455, 674\u2013678 (2008).","journal-title":"Nature"},{"key":"1026_CR35","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/nature08476","volume":"461","author":"H Ishikawa","year":"2009","unstructured":"Ishikawa, H., Ma, Z. & Barber, G. N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461, 788\u2013792 (2009).","journal-title":"Nature"},{"key":"1026_CR36","doi-asserted-by":"publisher","first-page":"19386","DOI":"10.1073\/pnas.1215006109","volume":"109","author":"J Ahn","year":"2012","unstructured":"Ahn, J., Gutman, D., Saijo, S. & Barber, G. N. STING manifests self DNA-dependent inflammatory disease. Proc. Natl Acad. Sci. USA 109, 19386\u201319391 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1026_CR37","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.4049\/jimmunol.1002620","volume":"186","author":"A Sahoo","year":"2011","unstructured":"Sahoo, A. et al. Stat6 and c-Jun mediate Th2 cell-specific IL-24 gene expression. J. Immunol. 186, 4098\u20134109 (2011).","journal-title":"J. Immunol."},{"key":"1026_CR38","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.4049\/jimmunol.164.8.4105","volume":"164","author":"K Tamada","year":"2000","unstructured":"Tamada, K. et al. LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J. Immunol. 164, 4105\u20134110 (2000).","journal-title":"J. Immunol."},{"key":"1026_CR39","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/cmi.2017.9","volume":"14","author":"CJ Kearney","year":"2017","unstructured":"Kearney, C. J., Randall, K. L. & Oliaro, J. DOCK8 regulates signal transduction events to control immunity. Cell Mol. Immunol. 14, 406\u2013411 (2017).","journal-title":"Cell Mol. Immunol."},{"key":"1026_CR40","doi-asserted-by":"publisher","first-page":"26860","DOI":"10.1074\/jbc.M109.037507","volume":"284","author":"JA Fulcher","year":"2009","unstructured":"Fulcher, J. A. et al. Galectin-1 co-clusters CD43\/CD45 on dendritic cells and induces cell activation and migration through Syk and protein kinase C signaling. J. Biol. Chem. 284, 26860\u201326870 (2009).","journal-title":"J. Biol. Chem."},{"key":"1026_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/srep16923","volume":"5","author":"M Wang","year":"2015","unstructured":"Wang, M., Zhao, Y. & Zhang, B. Efficient test and visualization of multi-set intersections. Sci. Rep. 5, 16923 (2015).","journal-title":"Sci. Rep."},{"key":"1026_CR42","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.chom.2016.03.001","volume":"19","author":"H Guo","year":"2016","unstructured":"Guo, H. et al. NLRX1 sequesters STING to negatively regulate the interferon response, thereby facilitating the replication of HIV-1 and DNA viruses. Cell Host Microbe 19, 515\u2013528 (2016).","journal-title":"Cell Host Microbe"},{"key":"1026_CR43","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1126\/science.1240933","volume":"341","author":"D Gao","year":"2013","unstructured":"Gao, D. et al. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 341, 903\u2013906 (2013).","journal-title":"Science"},{"key":"1026_CR44","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.immuni.2018.09.016","volume":"49","author":"A Marcus","year":"2018","unstructured":"Marcus, A. et al. Tumor-derived cGAMP triggers a STING-mediated interferon response in non-tumor cells to activate the NK cell response. Immunity 49, 754\u2013763 (2018).","journal-title":"Immunity"},{"key":"1026_CR45","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3389\/fimmu.2017.00818","volume":"8","author":"A Zaal","year":"2017","unstructured":"Zaal, A. et al. Anaphylatoxin C5a regulates 6-sulfo-LacNAc dendritic cell function in human through crosstalk with Toll-like receptor-induced CREB signaling. Front. Immunol. 8, 818 (2017).","journal-title":"Front. Immunol."},{"key":"1026_CR46","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.it.2003.12.005","volume":"25","author":"B Moser","year":"2004","unstructured":"Moser, B., Wolf, M., Walz, A. & Loetscher, P. Chemokines: multiple levels of leukocyte migration control. Trends Immunol. 25, 75\u201384 (2004).","journal-title":"Trends Immunol."},{"key":"1026_CR47","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S0014-5793(99)00161-1","volume":"445","author":"QH Liu","year":"1999","unstructured":"Liu, Q. H. et al. Expression and a role of functionally coupled P2Y receptors in human dendritic cells. FEBS Lett. 445, 402\u2013408 (1999).","journal-title":"FEBS Lett."},{"key":"1026_CR48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.tox.2011.07.001","volume":"288","author":"S Hara","year":"2011","unstructured":"Hara, S., Mizukami, H., Kuriiwa, F. & Mukai, T. cAMP production mediated through P2Y11-like receptors in rat striatum due to severe, but not moderate, carbon monoxide poisoning. Toxicology 288, 49\u201355 (2011).","journal-title":"Toxicology"},{"key":"1026_CR49","doi-asserted-by":"publisher","first-page":"12449","DOI":"10.1128\/JVI.01708-08","volume":"82","author":"GD Tomaras","year":"2008","unstructured":"Tomaras, G. D. et al. Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. J. Virol. 82, 12449\u201312463 (2008).","journal-title":"J. Virol."},{"key":"1026_CR50","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14, 7 (2013).","journal-title":"BMC Bioinformatics"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-021-01026-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-021-01026-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-021-01026-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T22:49:15Z","timestamp":1733957355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-021-01026-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,23]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1026"],"URL":"https:\/\/doi.org\/10.1038\/s41590-021-01026-9","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,23]]},"assertion":[{"value":"22 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.T. is an employee of Sanofi-Pasteur and provided the ALVAC vaccine components for all NHP and human studies. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}